| Literature DB >> 28444557 |
Shashank S Pawitwar1, Supurna Dhar2, Sneham Tiwari3, Chet Raj Ojha3, Jessica Lapierre3, Kyle Martins2, Alexandra Rodzinski1, Tiyash Parira3, Iru Paudel1, Jiaojiao Li1, Rajib Kumar Dutta3, Monica R Silva1, Ajeet Kaushik3, Nazira El-Hage4.
Abstract
There is growing evidence that Zika virus (ZIKV) infection is linked with activation of Guillan-Barré syndrome (GBS) in adults infected with the virus and microcephaly in infants following maternal infection. With the recent outpour in publications by numerous research labs, the association between microcephaly in newborns and ZIKV has become very apparent in which large numbers of viral particles were found in the central nervous tissue of an electively aborted microcephalic ZIKV-infected fetus. However, the underlying related mechanisms remain poorly understood. Thus, development of ZIKV-infected animal models are urgently required. The need to develop drugs and vaccines of high efficacy along with efficient diagnostic tools for ZIKV treatment and management raised the demand for a very selective animal model for exploring ZIKV pathogenesis and related mechanisms. In this review, we describe recent advances in animal models developed for studying ZIKV pathogenesis and evaluating potential interventions against human infection, including during pregnancy. The current research directions and the scientific challenges ahead in developing effective vaccines and therapeutics are also discussed.Entities:
Keywords: Autophagy; Neurological disorders; Vaccine; ZIKV animal models; ZIKV diagnosis; ZIKV pathology; Zika virus (ZIKV)
Mesh:
Year: 2017 PMID: 28444557 DOI: 10.1007/s11481-017-9743-8
Source DB: PubMed Journal: J Neuroimmune Pharmacol ISSN: 1557-1890 Impact factor: 4.147